BMS - Consensus statement.

Pitkin, Joan

Pitkin, Joan.

Afiliación

Pitkin J; Imperial College, Trustee BMS, Daisy Network, UK (previously Consultant Gynaecologist and Director of the Northwick Park Menopause Research and Clinical Unit, UK).

Post Reprod Health ; 24(3): 133-138, 2018 Sep.

Article en En | MEDLINE | ID: mdl-30244644

ABSTRACT

ABSTRACT

Urogenital atrophy is more common than it would first appear and women do not always seek advice and guidance. Confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations but new treatment modalities have emerged that extend the range of options beyond lubricants, moisturisers and vaginal estrogen preparations.

Asunto(s)

Vagina/patología; Vulva/patología; Atrofia/diagnóstico; Atrofia/etiología; Atrofia/terapia; Consenso; Terapia de Reemplazo de Estrógeno; Femenino; Humanos; Terapia por Láser; Lubricantes/uso terapéutico; Moduladores Selectivos de los Receptores de Estrógeno/uso terapéutico; Sexualidad; Tamoxifeno/análogos & derivados; Tamoxifeno/uso terapéutico

Palabras clave

dryness dyspareunia; genito-urinary syndrome of menopause (GSM); non-hormonal ubricants and moisturisers; pruritus; sexual dysfunction; urogenital atrophy; vaginal soreness; vulvovaginal atrophy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vagina / Vulva Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline Límite: Female / Humans Idioma: En Revista: Post Reprod Health Año: 2018 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google